Ingredient

Dapagliflozin Propanediol Hydrate

Dapagliflozin propanediol hydrate is a blood glucose-lowering component used in the treatment of type 2 diabetes.

All medicines
271
Single ingredient
99
Combination
172
Prescription medication
271

MFDS ingredient code M258339

What does it do?

Dapagliflozin propanediol hydrate belongs to the SGLT2 inhibitor class of diabetes medications. This component is primarily used for the control of blood glucose in patients with type 2 diabetes. It reduces the reabsorption of glucose in the kidneys, leading to lower blood glucose levels.

This component inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, increasing the amount of glucose excreted in the urine. As a result, the concentration of glucose in the blood decreases, helping to regulate blood sugar levels. This action lowers blood glucose by a pathway different from insulin.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Dapagliflozin propanediol hydrate is similar to other SGLT2 inhibitors, but is characterized by enhanced stability in the form of propanediol hydrate. Additionally, it does not directly stimulate insulin secretion, resulting in a relatively lower risk of hypoglycemia.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

271 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.